ClinicalTrials.Veeva

Menu

Transcutaneous Electrical Muscle Stimulation In Chronic Obstructive Pulmonary Disease (COPD)

T

The University Clinic of Pulmonary and Allergic Diseases Golnik

Status

Completed

Conditions

Chronic Obstructive Pulmonary Disease

Treatments

Device: Transcutaneous electrical muscle stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT01226342
Golnik-COPD-TENS-1

Details and patient eligibility

About

Transcutaneous electrical muscle stimulation (TCEMS) is well established intervention for rehabilitation of clinically stable patients with chronic obstructive pulmonary disease.

The investigators have conceived this study to test whether TCEMS is feasible and tolerated by patients experiencing severe physical and psychical challenge of acutely exacerbated COPD.

Enrollment

19 patients

Sex

All

Ages

35 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • chronic obstructive pulmonary disease GOLD stage III or IV
  • acute exacerbation of the disease

Exclusion criteria

  • contraindications for transcutaneous electrical muscle stimulation

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

19 participants in 1 patient group

TCEMS
Experimental group
Description:
Patients who will receive transcutaneous electrical muscle stimulation
Treatment:
Device: Transcutaneous electrical muscle stimulation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems